Christensen IJ - Search Results

1

Prediction of fulvestrant efficacy in patients with advanced breast cancer: retrospective-prospective evaluation of the predictive potential of a multigene expression assay.

Christensen TD, Buhl ASK, Christensen IJ, Buhl IK, Balslev E, Knoop AS, Danø H, Glavicic V, Luczak A, Langkjer ST, Linnet S, Jakobsen EH, Bogovic J, Ejlertsen B, Rasmussen A, Hansen A, Knudsen S, Jensen PB, Nielsen D. Christensen TD, et al. Among authors: christensen ij. Breast Cancer. 2020 Mar;27(2):266-276. doi: 10.1007/s12282-019-01017-7. Epub 2019 Oct 25. Breast Cancer. 2020. PMID: 31654283

2

Doxorubicin sensitivity pattern in a panel of small-cell lung-cancer cell lines: correlation to etoposide and vincristine sensitivity and inverse correlation to carmustine sensitivity.

Jensen PB, Roed H, Sehested M, Demant EJ, Vindeløv L, Christensen IJ, Hansen HH. Jensen PB, et al. Among authors: christensen ij. Cancer Chemother Pharmacol. 1992;31(1):46-52. doi: 10.1007/BF00695993. Cancer Chemother Pharmacol. 1992. PMID: 1360876

3

Reduced variation in the clonogenic assay obtained by standardization of the cell culture conditions prior to drug testing on human small cell lung cancer cell lines.

Jensen PB, Roed H, Vindeløv L, Christensen IJ, Hansen HH. Jensen PB, et al. Among authors: christensen ij. Invest New Drugs. 1989 Nov;7(4):307-15. doi: 10.1007/BF00173760. Invest New Drugs. 1989. PMID: 2557299

4

Differential cytotoxicity of 19 anticancer agents in wild type and etoposide resistant small cell lung cancer cell lines.

Jensen PB, Christensen IJ, Sehested M, Hansen HH, Vindeløv L. Jensen PB, et al. Among authors: christensen ij. Br J Cancer. 1993 Feb;67(2):311-20. doi: 10.1038/bjc.1993.58. Br J Cancer. 1993. PMID: 8094293 Free PMC article.

5

Flow cytometric DNA ploidy defines patients with poor prognosis in node-negative breast cancer.

Balslev I, Christensen IJ, Rasmussen BB, Larsen JK, Lykkesfeldt AE, Thorpe SM, Rose C, Briand P, Mouridsen HT. Balslev I, et al. Among authors: christensen ij. Int J Cancer. 1994 Jan 2;56(1):16-25. doi: 10.1002/ijc.2910560105. Int J Cancer. 1994. PMID: 8262673

6

In vitro cross-resistance and collateral sensitivity in seven resistant small-cell lung cancer cell lines: preclinical identification of suitable drug partners to taxotere, taxol, topotecan and gemcitabin.

Jensen PB, Holm B, Sorensen M, Christensen IJ, Sehested M. Jensen PB, et al. Among authors: christensen ij. Br J Cancer. 1997;75(6):869-77. doi: 10.1038/bjc.1997.154. Br J Cancer. 1997. PMID: 9062409 Free PMC article.

7

Low-level resistance to camptothecin in a human small-cell lung cancer cell line without reduction in DNA topoisomerase I or drug-induced cleavable complex formation.

Sorensen M, Sehested M, Christensen IJ, Larsen JK, Jensen PB. Sorensen M, et al. Among authors: christensen ij. Br J Cancer. 1998 Jun;77(12):2152-61. doi: 10.1038/bjc.1998.360. Br J Cancer. 1998. PMID: 9649127 Free PMC article.

8

Sequential versus combined treatment of human breast cancer cells with antiestrogens and the vitamin D analogue EB1089 and evaluation of predictive markers for vitamin D treatment.

Christensen GL, Jepsen JS, Fog CK, Christensen IJ, Lykkesfeldt AE. Christensen GL, et al. Among authors: christensen ij. Breast Cancer Res Treat. 2004 May;85(1):53-63. doi: 10.1023/B:BREA.0000021047.37869.95. Breast Cancer Res Treat. 2004. PMID: 15039597

9

Malignant transformation of wild-type but not plasminogen activator inhibitor-1 gene-deficient fibroblasts decreases cellular sensitivity to chemotherapy-mediated apoptosis.

Lademann U, Rømer MU, Jensen PB, Hofland KF, Larsen L, Christensen IJ, Brünner N. Lademann U, et al. Among authors: christensen ij. Eur J Cancer. 2005 May;41(7):1095-100. doi: 10.1016/j.ejca.2005.02.010. Eur J Cancer. 2005. PMID: 15862760

10

High serum levels of YKL-40 in patients with squamous cell carcinoma of the head and neck are associated with short survival.

Roslind A, Johansen JS, Christensen IJ, Kiss K, Balslev E, Nielsen DL, Bentzen J, Price PA, Andersen E. Roslind A, et al. Among authors: christensen ij. Int J Cancer. 2008 Feb 15;122(4):857-63. doi: 10.1002/ijc.23152. Int J Cancer. 2008. PMID: 17957792 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

452 results

Search Page